QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook
1. QIAGEN's Q1 2025 results surpassed sales and earnings expectations. 2. Net sales increased by approximately 5%, exceeding prior guidance.